WASHINGTON: Two Department of Health and Human Services agencies have picked up option years in contracts with Ogilvy Public Relations. The extensions mean an additional $12.3 million in work for the WPP Group firm.
The National Institute of Diabetes and Digestive and Kidney Diseases has granted the firm a $2.3 million extension to continue work on its national kidney disease education program. As part of the contract, Ogilvy is performing promotional activities meant to improve early detection of chronic kidney disease, identify patients at the greatest risk, and raise awareness of evidence-based interventions, said William Polglase, spokesman for the institute.
Chronic kidney disease affects an estimated 26 million Americans, according to the institute. Ogilvy's scope of work includes strategic planning, project management and administration, materials development and dissemination, communications planning and outreach, and meeting and exhibit support.
Anna Zawislanski, SVP for social marketing at Ogilvy Washington, said it has worked with the institute since 2003 and will continue “efforts in improving the detection and treatment of kidney disease in the primary-care setting.”
Meanwhile, the Agency for Healthcare Research & Quality has awarded the firm $10 million in contracts to continue work on two programs, the first of which is the National Initiative for Promoting Evidence-Based Health Information.
Ogilvy's goal on that effort is to raise awareness of the benefits of evidence-based healthcare, according to Allison Hunt, health communications specialist at the Agency for Healthcare Research and Quality.
The firm's scope of work includes marketing the latest research and maintaining campaigns that promote the benefits of using patient-centered outcomes in research in healthcare decision making among consumers and health professionals. Ogilvy is assisting with traditional and social media outreach, PSAs, and meeting and event management.
Ogilvy is also working with the Agency for Healthcare Research and Quality to support its regional partnership development offices initiative. Collaborations developed through the program enhance awareness, understanding, and use of patient-centered outcome research by groups representing patients and consumers, healthcare providers and systems, and businesses, according to information provided by Hunt.
Ogilvy declined to comment on the work it is doing for the Agency for Healthcare Research and Quality.